Navigation Links
Genes Identified That Enhance Tumor Cell Sensitivity to CTI's Cancer Drug Brostallicin
Date:4/20/2009

Identifies potential clinical trial strategies for personalized approach to cancer treatment

SEATTLE, April 21 /PRNewswire-FirstCall/ -- Systems Medicine, LLC (SM), a wholly-owned subsidiary of Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC), presented data from a preclinical study, which utilized RNA interference (RNAi) and bioinformatics to identify genetic markers - "contexts of vulnerability" - that enhance the anti-tumor response to the experimental drug candidate brostallicin, at the 2009 American Association for Cancer Research (AACR) annual meeting in Denver, Colorado. "Contexts of vulnerability" refers to the genetic configuration in a patient's tumor that makes it susceptible to a specific drug thus providing the genetic rationale for targeted therapy. The study's objective was to identify molecular determinants of brostallicin's anti-tumor response that could guide clinical development and drug combination studies by incorporating an integrated pharmacogenomics approach. The study was conducted by SM in collaboration with the Translational Genomics Research Institute's Pharmaceutical Genomics Division in Scottsdale, Arizona.

"This study has identified certain patient groups which might be more likely to benefit from therapy with brostallicin and have been invaluable in assisting us in identifying promising clinical development strategies for future development of this novel drug candidate," said Jack Singer, M.D., Chief Medical Officer of CTI. "Ultimately, we believe this approach should shorten the clinical development time and increase the success rate by bringing us closer to being able to offer the right drug to the appropriate patient."

Brostallicin is a small-molecule chemotherapeutic agent with a unique mechanism of action -- it binds to the minor grooves located in the DNA double helix. To identify genes associated with cellular response to brostallicin, a high-throughput RNA interfe
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ThermoGenesis Announces MXP Involvement in New Regenerative Medicine Initiatives
2. Why Wait for an Anti-Aging Drug? Researchers Interviewed on CBS-TVs 60 MINUTES Discover Longevinex(R) Nutriceutical Matrix Activates 9-Fold More Longevity Genes than Plain Resveratrol
3. STALLERGENES: Oralair(R) Grasses Obtains a Pediatric MA(1) in Germany
4. OmegaGenesis Unveils Novel Nanotechnology Platform With Broad Biomedical Applications
5. Breakthrough Mapping of Alzheimers Genome Helps ID Four New Suspect Genes
6. Neuronascent, Inc. Receives Multiple Fundings for Its Neurogenesis Therapeutic Programs
7. Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection
8. New Genes Found for Inflammatory Bowel Disease in Children
9. Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber
10. Cardiogenesis Announces Preliminary Clinical Results With the PHOENIX System Combining TMR + Stem Cells
11. NARSAD Researchers Identify Specific Genes and Family Traits Linked to Schizophrenia, Bipolar Disorder and Depression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) announces the ... StockholdersWhen:Tuesday, June 30 at 5:10 p.m. ET / 2:10 ... onto our website listed above.   If ... a replay of the webcast will be available for ... ABOUT ISIS PHARMACEUTICALS, INC. Isis is exploiting ...
(Date:6/29/2015)... 30, 2015 , Gerresheimer will sell ... and Gerresheimer enter into a 10-year-supply agreement for pharmaceutical ... EUR 196m debt-free Corning and Gerresheimer will ... glass packaging market Gerresheimer,s outlook for the financial ... disposal of the tubing business , In line ...
(Date:6/29/2015)... 29, 2015  Nevro Corp. (NYSE: NVRO ), ... evidence-based solutions for the treatment of chronic pain, today ... Executive Officer of Intersect ENT (NASDAQ: XENT ), ... June 28, 2015. For the last ... Intersect ENT, a company dedicated to improving the quality ...
Breaking Medicine Technology:Webcast Alert: Corporate Presentation at the 2015 Isis Pharmaceuticals Annual Stockholder Meeting 2Webcast Alert: Corporate Presentation at the 2015 Isis Pharmaceuticals Annual Stockholder Meeting 3Gerresheimer Will Sell Tubing Operations to Corning - Both Will Form a Joint Venture to Accelerate Innovations for Pharmaceutical Glass Packaging Market 2Gerresheimer Will Sell Tubing Operations to Corning - Both Will Form a Joint Venture to Accelerate Innovations for Pharmaceutical Glass Packaging Market 3Nevro Appoints Lisa Earnhardt to its Board of Directors 2
... HAIFA, Israel, November 11 Cardio Vascular,Medical ... advanced,cardiovascular surgery technology, today announced the completion of ... . , Cardio Vascular ... innovative,next-generation "steerable guidewire" applicable for all angioplasty (PCTA),procedures. ...
... ACCESS PHARMACEUTICALS, INC. (OTC Bulletin ... commercial launch of MuGard, an FDA approved treatment for oral ... Access intends to commercially launch MuGard in North America ... pertaining to the launch include: , Manufacturing : ...
Cached Medicine Technology:Cardio Vascular Medical Device Launches Corporate Website 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North America 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North America 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North America 4
(Date:6/30/2015)... ... June 30, 2015 , ... The Citizens Commission ... Davis (D-IL) for writing to the Department of Health and Human Services (HHS), ... healthcare system, Universal Health Services (UHS).[1] CCHR is expanding its seven-year review of ...
(Date:6/30/2015)... ... June 30, 2015 , ... Nuretix Research, creators of ... Zone Miami (KO Zone), a state-of-the-art training facility owned by leading ... de Vera. The partnership will provide KO Zone clients and athletes with Liporidex ...
(Date:6/30/2015)... ... June 30, 2015 , ... Under ... protection at less thickness than any other padding in football. , Developed in ... and shock absorption, Gameday Armour is engineered with D3O protective polymer. This radical ...
(Date:6/30/2015)... ... June 30, 2015 , ... Experts estimate that up to ... Back pain can range from a dull, constant ache (chronic) to a sudden sharp ... epidural steroid injections, selective nerve root blocks and rhizotomy treatment, OPTIMAL Pain & ...
(Date:6/30/2015)... ... 30, 2015 , ... People who want to learn more ... a near-death experience (NDE) – and also want to understand why the military ... – are invited to visit https://zoom.us/webinar/register/f4a12556fe7c03f5dc2040ba88984b7b and RSVP their attendance at ...
Breaking Medicine News(10 mins):Health News:CCHR Seeks Public Input on Psychotropic Drug Billing and Psychiatric Abuse: Applauds Congressmen for Behavioral Hospitals Investigation Call 2Health News:CCHR Seeks Public Input on Psychotropic Drug Billing and Psychiatric Abuse: Applauds Congressmen for Behavioral Hospitals Investigation Call 3Health News:CCHR Seeks Public Input on Psychotropic Drug Billing and Psychiatric Abuse: Applauds Congressmen for Behavioral Hospitals Investigation Call 4Health News:CCHR Seeks Public Input on Psychotropic Drug Billing and Psychiatric Abuse: Applauds Congressmen for Behavioral Hospitals Investigation Call 5Health News:Top Sports Nutrition Brand, Liporidex, Announces Partnership With Leading Boxing, CrossFit and MMA Gym, Knockout Zone of Miami 2Health News:Top Sports Nutrition Brand, Liporidex, Announces Partnership With Leading Boxing, CrossFit and MMA Gym, Knockout Zone of Miami 3Health News:Under Armour Launches Advanced Gameday Armour® Max Protection System For The Gridiron 2Health News:OPTIMAL Pain & Regenerative Medicine Brings Innovative Back Pain Management Options Including PRP Injections and Stem Cell-like Therapies to Dallas/Ft. Worth Metroplex 2Health News:OPTIMAL Pain & Regenerative Medicine Brings Innovative Back Pain Management Options Including PRP Injections and Stem Cell-like Therapies to Dallas/Ft. Worth Metroplex 3Health News:IANDS Sponsors No-Cost Webinar on July 1/15 at 11CST Featuring Combat Soldier Who Survived Near-Death Experience 2Health News:IANDS Sponsors No-Cost Webinar on July 1/15 at 11CST Featuring Combat Soldier Who Survived Near-Death Experience 3
... Assia, of Tel Aviv Universitys Sackler School of Medicine is, ... surgery. , One of a small number of surgeons in ... surgery, Prof. Assia has developed a novel laser device that ... the OTS134 for now, is expected to give most practicing ...
... Sept. 14, 2007 -- A new study by researchers at ... be good for you. , Researchers found that a ... with teen obesity, hypertension and healthy eating habits had a ... among men. , The study, published in the Sept. 14 ...
... department reported that their anxiety levels fell dramatically when they ... research in the September issue of the UK-based Journal of ... provided over the course of a year. 86 nurses participated ... summer and winter sessions. , Researchers found that 60 ...
... kill off cancer cells, experts say , FRIDAY, Sept. ... called unplanned cell death, or necrosis, could help in ... life-threatening conditions, scientists say. , Necrosis is not the ... Necrosis is an unplanned cell death caused by outside ...
... offers possible advance over invasive tests , , FRIDAY, Sept. ... a mother-to-be,s blood could become the lens through which ... a new study suggests. , "It,s amazing that all ... in their blood," said Dr. Jill L. Maron, the ...
... N.J., Sept. 21 Schering-Plough,Corporation (NYSE: SGP ) ... the 2007 third quarter on Monday, Oct. 22, 2007. ... will conduct a conference,call to review results for the ... other members of management will,host the conference call. ...
Cached Medicine News:Health News:Glaucoma surgery in the blink of an eye 2Health News:ER episode impacts viewers' health knowledge and behavior 2Health News:Giving emergency nurses aromatherapy massages with music dramatically reduced stress levels 2Health News:Giving emergency nurses aromatherapy massages with music dramatically reduced stress levels 3Health News:Clues to Cell Death Could Fight Disease 2Health News:Mother's Blood Could Offer Insights Into Fetal Health 2Health News:Mother's Blood Could Offer Insights Into Fetal Health 3
Shandon Microscope Slide Cabinet with Drawers...
... data from multiple sources is not ... ResultNet/Plus software allows you to concentrate ... communications network., ,ResultNet/Plus eliminates the complexity ... largescale or multi-site laboratories to host ...
The flexible EXXCEL ePTFE Vascular Access Graft material is designed to offer textile-like handling characteristics-cuts neatly for a clean edge, retains fully open lumen shape, and sutures smoothly....
ACE Control Serum provides the laboratory with vital information on the performance of the ACE chemistry assay....
Medicine Products: